Medical treatment for Graves' disease: principles, markers of a relapse and remission
https://doi.org/10.14341/probl200551644-49
Abstract
Graves' disease (diffuse toxic goiter) is a systemic autoimmune disease that develops as a result of the production of antibodies to the thyroid stimulating hormone receptor (AT-rTSH), which is clinically manifested by thyroid damage with the development of thyrotoxicosis syndrome in combination with extrathyroid pathology (pretibial endocrine) myxedema, acropathy). The disease was first described by S. Ives in 1722, then Peri in 1786 and Flayani in 1802. In 1835, R. Graves associated the occurrence of the described symptom complex, now known as thyrotoxicosis syndrome, with thyroid pathology. In 1840, K. Bazedov singled out a triad in the clinical picture: goiter, buccalis, tachycardia.
About the Authors
N. A. AbramovaI.M.Sechenov Moscow Medica Academy
Russian Federation
V. V. Fadeyev
I.M.Sechenov Moscow Medica Academy
Russian Federation
References
1. Герасимов Г.А., Мельниченко Г.А., Федак И.Р. // Пробл. эндокринол. - 1997. - № 1. - С. 28-31.
2. Петровский Б.В., Семенов В.С. Клиника и хирургическое лечение тиреотоксического зоба. - М., 1961. 3.Чистяков Д.А., Савостьянов К.В. // Пробл. эндокринол. - 2001. - Т.47, № 2. - С. 3-4.
3. Akazu F., Kasuga Y., Matsubayashi S. et al. // Thyroid. - 1991. - Vol.1. - P. 215-222.
4. Allahabadia A., Daykin J., Holder R.L. et al. // J. Clin. Endo- crinol. Metab. - 2000. - Vol.85. - P. 1038-1042.
5. Azizi F. // Thyroid. - 1995. - Vol.5. - P. 108-111.
6. Baldini M., Castagnone D., Rivolta R. et al. // Thyroid. - 1997. - Vol.7. - P. 823-828.
7. Barlow А.В.Т., Wheatcroft N., Watson P., Weetman A. // Clin. Endocrinol. - 1996. - Vol.44. - P. 73-78.
8. Baskm H., Cobin R.H., Duick D.S. et al. // Endocr. Pract. - 2002. - Vol.8. - P. 457-467.
9. Benker G., Rainwein D., Kahaly G. et al. // Clin. Endocrinol. - 1998. - Vol.49. - P. 451-457.
10. Chan J.Y.C., Walfish P.G. // J. Clin. Endocrinol. Metab. - 1986. - Vol.62. - P. 403-409.
11. Cooper D.S. // The Thyroid. // Eds Braverman L., Utiger R. - 6-th Ed. - Philadelphia, 1991. - P. 887-916.
12. Cooper D.S. /I Endocrinol. Metab. Clin. N. Am. - 1998. - Vol.27. - P. 225-247.
13. Corrales J.J., Lypez A., Ciudad J., Orfao A. // J. Biol. Regulat. Homeostat. Agents. - 2000. - Vol.14. - P. 193-199.
14. Edan G., Massart C., Hody B. et al. // Br. Med. J. - 1989. - Vol.298. - P. 359-361.
15. Engler H., Taurog A., Dorris M.L. // Endocrinology. - 1992. - Vol.110. - P. 190-197.
16. Feldt-Rasmussen U., Glinoer D., Orgiazzi J. // Ann. Rev. Med. - 1993. - Vol.44. - P. 323-334.
17. Feldt-Rasmussen U., Schleusener H., Carayon P. // J. Clin. Endocrinol. Metab. - 1994. - Vol.78. - P. 98-102.
18. Gamstedt A., Wadman В., Karlsson A. et al. // J. Clin. Endocrinol. Metab. - 1986. - Vol.62. - P. 773-777.
19. Genestein H., Rastogi В., Iwatani Y. et al. // Clin. Invest. Med. - 1987. - Vol.10. - P. 337-344.
20. Glinoer D., de Nayer P., Bex M. // Eur. J. Endocrinol. - 2001. - Vol.144. - P. 475-483.
21. Hallinfsworth D.R., Marby C.C., Eckerd J.M. et al. // J. Pediatr. - 1972. - Vol.81. - P. 446-459.
22. Hedley A.J., Young R.E., Jones S.J. et al. // Clin. Endocri-nol. - 1989. - Vol.31. - P. 209-218.
23. Heufelder A.E., Goellner J.R., Wenzel B.E. et al. // J. Clin. Endocrinol. Metab. - 1992. - Vol.74. - P. 724-731.
24. Reward J.M., Allahabadia A., Daykin J. et al. // J. Clin. Endocrinol. - 1998. - Vol.82. - P. 3394-3397.
25. Hiromatsu Y., Fukazawa H., Wall J.R. et al. // Endocrinol. Clin. N. Am. - 1987. - Vol.16. - P. 269-286.
26. Jacobson D.L, Gange S.J., Rose N.R., Graham N. // Clin. Immunol. Immunopathol. - 1997. - Vol. 84. - P. 223-243.
27. Jorde R., Ytre-Arne K., Styrmer J., Sundsfford J. // J. Intern. Med. - 1995. - Vol.238. - P. 161-165.
28. Kasagi K., Iida Y., Hatabu H. et al. // Acta Endocrinol. (Copenh.). - 1988. - Vol.117. - P. 173-180.
29. Komiya I., Yamada Т., Sato A. et al. // J. Clin. Endocrinol. Metab. - 2001. - Vol.86. - P. 3540-3544.
30. Koukkou E., Panayiotidis P., Alevizou-Terzaki V. et al. // J. Clin. Endocrinol. Metab. - 1991. - Vol.73. - P. 771-776.
31. Laurberg P., Pedersen K.M., Vestergaard H., Sigurdsson G. // J. Intern. Med. - 1991. - Vol.229. - P. 415-420.
32. Leech N.J., Dayan C.D. // Clin. Endocrinol. - 1998. - Vol.49. - P. 273-280.
33. Lucas A., Salinas L, Rius F. et al. // J. Clin. Endocrinol. Me-tab. 1997. - Vol.82. - P. 2410-2413.
34. Mariotti S., Caturegli P., Barbesino G. et al. // Clin. Endocri-nol. - 1992. - Vol.37. - P. 415-422.
35. Massart C., Sonnet E., Gibassier J. et al. // Clin. Chim. Acta. - 1997. - Vol.265. - P. 157-168.
36. Michelangeli V., Poon C., Toft J. et al. // Thyroid. - 1998. - Vol.8. - P. 119-124.
37. Nicholas W.C., Fischer R.S., Stevenson R.A. et al. // South. Med. J. - 1995. - Vol.88. - P. 973-976.
38. Orgiazzi J., Madec A.-M. // Thyroid. - 2002. - Vol.12. - P. 849-853.
39. Papac M., Stein-Streilein J., Zakarija M. et al. // J. Clin. Invest. - 1987. - Vol.79. - P. 404-409.
40. Peterson K., Bengtsson C., Lapidus L. et al. // Arch. Intern. Med. - 1990. - Vol.150. - P. 2077-2081.
41. Pfeilschifter J., Zeigler R. // Eur. J. Endocrinol. - 1997. - Vol.136. - P. 81-86.
42. Prummel M.F., Wiersinga W.M. // J. A. M. A. - 1993. - Vol.269. - P. 479-482.
43. Reglinski J., Smith W., Wilson R. et al. // Clin. Endocrinol. - 1992. - Vol.37. - P. 319-324.
44. Reinwein D., Bender G., Lazarus J.H. et al. // J. Clin. Endocrinol. Metab. - 1993. - Vol.76. - P. 1516-1521.
45. Romaldini J.H., Bromberg N., Werner R. et al. // J. Clin. Endocrinol. Metad. - 1983. - Vol.57. - P. 563-570.
46. Rosch P. // Lancet. - 1993. - Vol.342. - P. 566-567.
47. Shleusener H., Schewander J., Holl G. et al. // Acta Endocrinol. (Copeng.). - 1987. - Vol.281. - P. 318-324.
48. Shleusener H., Schwander J., Fischer C. et al. // Acta Endocrinol. (Copeng.). - 1989. - Vol.120. - P. 689-701.
49. Skillern P.G. // Mayo Clin. Proc. - 1972. - Vol.93. - P. 848-849.
50. Takamatsu J., Кита К., Mozai Т. et al. // J. Clin. Endocrinol. Metab. - 1986. - Vol.62. - P. 980-983.
51. Torring O., Tallstedt L., Wallin G. et al. // J. Clin. Endocrinol. Metab. - 1996. - Vol.81. - P. 2986-2993.
52. Totterman T.H., Karlsson F.A., Bengtsson M. et al. // N. Engl. J. Med. - 1987. - Vol.316. - P. 15-22.
53. Utiger R.D. // N. Engl. J. Med. - 1995. - Vol.333. - P. 1001-1002.
54. Vitti P., Rago Т., Chiovato L. et al. // Thyroid. - 1997. - Vol.7. - P. 369-375.
55. Vitug A.C., Goldman J.M. // Horm. Res. - 1985. - Vol.21. - P. 229-234.
56. Volpe R. // Curr. Pharmaceut. Desing. - 2001. - Vol.7. - P. 451-460.
57. Wartofsky L. // Thyroid. - 1997. - Vol.7. - P. 213-216.
58. Weetman A.P., Pickerill A.P., Watson P. et al. // Quart. J. Med. - 1994. - Vol.87. - P. 337-341.
59. Weetman A.P. // N. Engl. J. Med. - 2000. - Vol.343. - P. 1236-1248.
60. Young E.Т., Steel N.R., Talor J.J. et al. // Quart. J. Med. - 1998. - Vol.250. - P. 175-189.
61. Zingrillo M., D'Aloiso L, Ghiggi M.R. et al. // Clin. Endocrinol. - 1996. - Vol.45. - P. 564-569.
Review
For citations:
Abramova N.A., Fadeyev V.V. Medical treatment for Graves' disease: principles, markers of a relapse and remission. Problems of Endocrinology. 2005;51(6):44-49. (In Russ.) https://doi.org/10.14341/probl200551644-49
Views:
20927
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
